ow carbohydrate diets weight loss and heart disease
Active, not recruiting
- Conditions
- ObesityDiet and Nutrition - Obesity
- Registration Number
- ACTRN12605000614695
- Lead Sponsor
- CSIRO Human Nutrition
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Active, not recruiting
- Sex
- All
- Target Recruitment
- 90
Inclusion Criteria
BMI 27-40 kg/m2, Fasting glucose 6 -7 mmol/L and/or triglycerides >1.7mmol/L and/or HDL-C < 0.9 in men <1.0 mmol/L in women.
Exclusion Criteria
No exclusion criteria
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Cardiovascular disease risk markers[At baseline, after 12 weeks of weight loss and 52 weeks]
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What are the primary clinical endpoints of ACTRN12605000614695 on low/high-carb diets and metabolic syndrome?
How do low-carb diets affect endothelial function via AMPK/SIRT1 pathways in metabolic syndrome?
Which biomarkers predict cardiovascular response to low-carb diets in metabolic syndrome patients?
What adverse events are associated with low-carb weight loss diets in metabolic syndrome?
How does combining low-carb diets with GLP-1 agonists enhance metabolic syndrome outcomes?